Clinical Trial

The Role Intraoperative Salbutamol Inhaler in Preventing Atelectasis

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
Atelectasis is considered a common complication in the perioperative period, especially following surgeries under general anesthesia. Postoperative atelectasis could occur anytime during the perioperative period from intraoperative period to 24 hours postoperative and contribute to a variety of other complications, including hypoxemia and pneumonia. In the literature, several methods were utilized to combat this phenomenon, therefore, we investigate the role of intraoperative salbutamol in reducing the incidence of atelectasis. It is well known that salbutamol could be an adjunctive bronchodilator medication used in the intraoperative anesthetic regimens.
Trial Details
NCT Number NCT07591558
Lead Sponsor King Abdullah University Hospital
Collaborators: Jordan University of Science and Technology
Conditions Atelectases, Postoperative Pulmonary, Diabete Mellitus
Enrollment 80 participants
Start Date 2026-06
Primary Completion 2026-10 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-15